Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.790
-0.030 (-1.06%)
At close: Sep 17, 2026, 4:00 PM EDT
2.800
+0.010 (0.36%)
After-hours: Sep 17, 2026, 7:30 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $63.69 million as of September 17, 2026. Its market cap has increased by 147.42% in one year.
Market Cap
63.69M
Enterprise Value
-8.94M
1-Year Change
147.42%
Ranking
Category
Stock Price
$2.79
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $63.69M, a decrease of -82.10%. That is a compound annual growth rate of -50.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 63.69M | 137.11% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 68.22M |
| Alterity Therapeutics | 67.68M |
| XBiotech | 67.07M |
| Alps Group | 66.51M |
| Spero Therapeutics | 66.10M |
| LeonaBio | 65.48M |
| Gossamer Bio | 64.28M |
| Rein Therapeutics | 62.82M |